Works matching Hormone receptor tests


Results: 73
    1
    2
    3

    Clinical validation of an immunohistochemistry‐based CanAssist‐Breast test for distant recurrence prediction in hormone receptor‐positive breast cancer patients.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 4, p. 1755, doi. 10.1002/cam4.2049
    By:
    • Bakre, Manjiri M.;
    • Ramkumar, Charusheila;
    • Attuluri, Arun Kumar;
    • Basavaraj, Chetana;
    • Prakash, Chandra;
    • Buturovic, Ljubomir;
    • Madhav, Lekshmi;
    • Naidu, Nirupama;
    • R, Prathima;
    • Somashekhar, S. P.;
    • Gupta, Sudeep;
    • Doval, Dinesh Chandra;
    • Pegram, Mark D.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Pink Month.

    Published in:
    Medical Laboratory Observer (MLO), 2022, v. 54, n. 10, p. 6
    By:
    • Wichmann, Christina
    Publication type:
    Article
    13
    14
    15
    16
    17

    WORLD NEWS.

    Published in:
    Cancer Nursing Practice, 2008, v. 7, n. 7, p. 8
    By:
    • Birmingham, Karen
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Randomized Phase 3 Trial of Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 11, p. 805, doi. 10.1093/jnci/djn151
    By:
    • Martin, Miguel;
    • Rodriguez-Lescure, Álvaro;
    • Ruiz, Amparo;
    • Alba, Emilio;
    • Calvo, Lourdes;
    • Ruiz-Borrego, Manuel;
    • Munárriz, Blanca;
    • Rodriguez, César A.;
    • Crespo, Carmen;
    • de Alava, Enrique;
    • López García-Asenjo, José Antonio;
    • Guitián, María Dolores;
    • Almenar, Sergio;
    • González-Palacios, Jesús Fernando;
    • Vera, Francisco;
    • Palacios, José;
    • Ramos, Manuel;
    • Gracia Marco, Jose Manuel;
    • Lluch, Ana;
    • Alvarez, Isabel
    Publication type:
    Article
    32
    33

    Neoadjuvant Pyrotinib plus Trastuzumab, Docetaxel, and Carboplatin in Early or Locally Advanced Human Epidermal Receptor 2-Positive Breast Cancer in China: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

    Published in:
    Oncology Research & Treatment, 2023, v. 46, n. 7/8, p. 303, doi. 10.1159/000531492
    By:
    • Ding, Yuqin;
    • Mo, Wenju;
    • Xie, Xiaohong;
    • Wang, Ouchen;
    • He, Xiangming;
    • Zhao, Shuai;
    • Gu, Xidong;
    • Liang, Chenlu;
    • Qin, Chengdong;
    • Ding, Kaijing;
    • Yang, Hongjian;
    • Ding, Xiaowen
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41

    Decentral gene expression analysis for ER+/Her2− breast cancer: results of a proficiency testing program for the EndoPredict assay.

    Published in:
    Virchows Archiv: European Journal of Pathology, 2012, v. 460, n. 3, p. 251, doi. 10.1007/s00428-012-1204-4
    By:
    • Denkert, Carsten;
    • Kronenwett, Ralf;
    • Schlake, Werner;
    • Bohmann, Kerstin;
    • Penzel, Roland;
    • Weber, Karsten;
    • Höfler, Heinz;
    • Lehmann, Ulrich;
    • Schirmacher, Peter;
    • Specht, Katja;
    • Rudas, Margaretha;
    • Kreipe, Hans-Heinrich;
    • Schraml, Peter;
    • Schlake, Gudrun;
    • Bago-Horvath, Zsuzsanna;
    • Tiecke, Frank;
    • Varga, Zsuzsanna;
    • Moch, Holger;
    • Schmidt, Marcus;
    • Prinzler, Judith
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50